Showing results (1481-1490 of 3,615) with videos related to
Sort By:
Pageof 362
Journal of Viral Hepatitis|June 29, 2021
Persistent chronic immune activation in HIV/HBV-coinfected patients after antiretroviral therapyYaozu He, Weiping Cai, Jingliang Chen, et al.Journal of Viral Hepatitis|May 12, 2022
Closing the hepatitis C treatment gap: United States strategies to improve retention in careAustin T Jones, Christopher Briones, Torrence Tran, et al.Journal of Viral Hepatitis|May 13, 2022
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study GroupToshie Mashiba, Kouji Joko, Masayuki Kurosaki, et al.Journal of Viral Hepatitis|June 1, 2022
Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapiesJosé-Manuel Ramos-Rincon, Héctor Pinargote-Celorio, Carmen de Mendoza, et al.Journal of Viral Hepatitis|January 19, 2018
Increased oestradiol in hepatitis E virus-infected pregnant women promotes viral replicationC Yang, W Yu, Y Bi, et al.Journal of Viral Hepatitis|February 4, 2018
Differential virus-specific CD8+ T-cell epitope repertoire in hepatitis C virus genotype 1 versus 4Hendrik Luxenburger, Franziska Graß, Janina Baermann, et al.Journal of Viral Hepatitis|January 10, 2018
Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antiviralsH Cho, H Ahn, D H Lee, et al.Journal of Viral Hepatitis|December 6, 2018
Durable control of hepatitis C through interferon-free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantationKerstin Rauwolf, Heidi Herbrüggen, Stefan Zöllner, et al.Journal of Viral Hepatitis|December 15, 2018
Incidence of hepatitis E virus infection among blood donors in a high endemic area of Central ItalyCinzia Marcantonio, Patrizio Pezzotti, Roberto Bruni, et al.Journal of Viral Hepatitis|December 22, 2018
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis BElisabetta Loggi, Ranka Vukotic, Fabio Conti, et al.Pageof 362